Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 27 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
SIMBIOS INVEST from Brussel, company number BE0894112148, closed financial year 2025 with a result of € 2,551 after tax. For that financial year SIMBIOS INVEST recorded a gross margin of € 199,126 and equity of € 94,903. Compared with financial year 2024, the result moved from € 13,690 to € 2,551. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 22, 2025.
€ 94,903
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2,551
▼ 81% vs 2024
Profit after tax over the fiscal year.
€ 216,392
▲ € 179,617 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 76,303.
People and assets in 2025
0.5
▼ 0.3 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 16,008
▼ 53% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 40,320
▼ 57% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 257,958
▼ 20% vs 2024
€ 63,000 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.
€ 6,293
▲ 92% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 5,961
▼ 66% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 193,385 | € 178,850 | € 217,655 | € 199,126 | ▼ 9% |
| Profit after taxes | € 7,002 | € -902 | € 13,690 | € 2,551 | ▼ 81% |
| Equity | € 79,564 | € 78,662 | € 92,352 | € 94,903 | ▲ 3% |
| Total debts | € 1,004,061 | € 1,439,261 | € 1,334,840 | € 1,758,400 | ▲ 32% |
| Cash | € 42,807 | € 78,589 | € 36,774 | € 216,392 | ▲ € 179,617 |
| Land & buildings | € 720,166 | € 650,346 | € 710,893 | € 1,220,035 | ▲ 72% |
| Retained profit | € 60,964 | € 60,062 | € 73,752 | € 76,303 | ▲ 3% |
| Bank debt | € 406,402 | € 337,291 | € 320,958 | € 257,958 | ▼ 20% |
| Balance sheet total | € 1,083,625 | € 1,517,923 | € 1,427,192 | € 1,853,303 | ▲ 30% |
| Employees (FTE) | 1 | 0.8 | 0.8 | 0.5 | ▼ 0.3 |
Key figures of SIMBIOS INVEST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 December 2026.
What happened to SIMBIOS INVEST?
What happened at SIMBIOS INVEST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 2,551 (▼ 81% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Rochefort. KBO
- Kurt De Raeve became a director. NBB
In short
From € 7,002 profit in 2022 to € 2,551 profit in 2025.
Paid € 15,918 in corporate taxes since 2022.
Best year ever: 2024, with € 13,690 profit.
On average € 193,400 of value added per employee in 2022.
A new publication or filing at SIMBIOS INVEST? We notify you, reason included.
Follow SIMBIOS INVESTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SIMBIOS INVEST is Kurt De Raeve. It owns 100% of SIMBIOS, 100% of Excitit, 100% of QUASAS BV and 100% of Devgenix itself.
Establishments
Establishment units
Physical locations of this company
Lombardsijdestraat 217 box 1
1120 Brussel
Rue Lafayette 14
5580 Rochefort
Active since 5 December 2007
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →SIMBIOS same network
€ 774,257 gross margin · 2025
QUASAS same network
€ 522,008 gross margin · 2025
FITAMINE SPORT
EXCITIT same network
€ 362,721 gross margin · 2025
Devgenix same network
€ 599,183 gross margin · 2026
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0894.112.148
- VAT number
- BE 0894.112.148
- Registered office
- Lombardsijdestraat 217 bus 1, 1120 Brussel
- Names & denominations
- SIMBIOS INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 December 2007
- Peppol
- Active · Active since 12 Jan 2026
- Activities · NACE
Diverse ondersteunende activiteiten ten behoeve van voorzieningen